Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Rentech, Inc.(NASDAQ:RTK), Interactive Brokers Group, Inc.(NASDAQ:IBKR), Krispy Kreme Doughnuts(NYSE:KKD), Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)
Rentech, Inc.(NASDAQ:RTK) was a volume gainer of 2.01 million shares and the average volume of the stock remained 2.14 million shares. The stock opened the session at $1.81 and finished at the end of the day at $1.84 and the stock escalated 1.10%.The market capitalization of the stock remained 417.35 million. Rentech, Inc., through its subsidiaries, engages in the manufacture and sale of natural-gas based nitrogen fertilizer products in the United States and Brazil. Its products include ammonium sulfate, sulfuric acid, and ammonium thiosulfate used in the production of corn, soybeans, potatoes, cotton, canola, alfalfa, and wheat.
For How Long RTK will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Interactive Brokers Group, Inc.(NASDAQ:IBKR) exchanged 1.98 million shares and the average volume remained 467,660.00 shares. The stock closed the session at $23.25 with the drop of -3.97%. Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. It engages in routing orders; and executing and processing trades in securities, futures, foreign exchange instruments, bonds, and mutual funds on approximately 100 electronic exchanges and trading venues worldwide.
Why Should Investors Buy IBKR After the Recent Fall? Just Go Here and Find Out
Krispy Kreme Doughnuts(NYSE:KKD) decreased -0.31% and its closing price was $19.51. The volume of the stock was 1.96 million shares and the average volume remained 1.80 million shares. The market capitalization of the stock remained 1.29 billion. The beta of the stock remained 2.15. Krispy Kreme Doughnuts, Inc., together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, beverages, and treats and packaged sweets worldwide. It owns and franchises Krispy Kreme stores. As of December 12, 2013, the company operated approximately 810 stores worldwide.
Will KKD Get Buyers Even After The Recent Rally? Find Out Here
Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) exchanged 1.96 million shares in the previous trading session, and its average trading remained 947,062.00 shares. PGNX advanced 4.07% and it closed the trading at $6.13. The market capitalization of the stock remained 372.86 million. Progenics Pharmaceuticals, Inc. engages in the research and development of biotechnology product candidates in the areas of oncology and therapeutics worldwide. It has license agreement with Salix Pharmaceuticals, Inc. for the development and commercialization of RELISTOR worldwide other than Japan.
For How Long PGNX’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)